Laboratory Developed Tests Market Size and Share Analysis by Type, Application, End User - Global Industry Demand Forecast to 2030
세계의 LDT(Laboratory Developed Tests) 시장 규모는 2023년에 103억 7,580만 달러에서 CAGR 7.2%로 추이하여, 2030년에는 165억 3,990만 달러에 달할 전망입니다. 이 산업의 발전은 암이나 유전적 질환 증가로 인한 것이 큽니다.
또한, 이 성장은 현재 이 업계에서 희귀질환으로 인해 이용할 수 없는 시험관내 실험실에서 개발된 검사에 대한 요구가 증가하고 있기 때문입니다.
분자진단제 카테고리가 업계를 선도
2023년에는 분자진단제 카테고리가 40%의 점유율로 업계를 선도하고 있으며, 이는 향후 수년간 계속될 전망입니다. 그 배경에는 고령화 사회의 진전과 질병의 조기 발견에 대한 요구 증가가 있습니다.
암 카테고리가 가장 큰 시장 점유율을 차지
용도별로는 암의 조기 발견을 목적으로 한 첨단기술의 분자진단 접근에 대한 요구가 높아지고 있기 때문에 암 카테고리가 20%의 점유율을 차지해 업계를 리드하고 있습니다. 암은 사인의 2위를 차지하고 있습니다.
북미가 주요 수익을 창출
북미는 2023년에 약 40%의 점유율을 차지해 업계를 선도하고 있어 향후 수년간에도 견조한 성장을 보일 것으로 보입니다. 이는 이 지역의 첨단 검사실 인프라와 숙련된 직원 채용 가능성에 기인합니다.
세계의 LDT(Laboratory Developed Tests) 시장에 대해 분석했으며, 시장의 기본 구조/최신 정세/주요 촉진·억제 요인/세계 전체 및 지역별·주요 국가 시장 규모 동향 전망(수량 및 금액 기준, 2017-2030년)/유형별·용도별·최종 사용자별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 규모 : 지역별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 규모 : 국가별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 규모 : 유형별(2017-2030년)
- 시장 매출 : 유형별(2017-2030년)
- 시장 규모 : 용도별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 규모 : 최종 사용자별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Quest Diagnostics Incorporated
- Abbott Laboratories
- Illumina Inc.
- F. Hoffmann-La Roche Ltd.
- Siemens AG
- Bio-Rad Laboratories Inc.
- NeoGenomics Laboratories Inc.
- Guardant Health Inc.
- Becton, Dickinson and Company
- QIAGEN NV
제31장 부록
LYJ
The laboratory-developed tests market had a value of USD 10,375.8 million in 2023, which will power at a compound annual growth rate of 7.2%, to reach USD 16,539.9 million by 2030. The development of this industry is mostly powered by the increase in the occurrence of cancer and genetic ailments.
Furthermore, the growth is credited to the growing requirement for in vitro laboratory-developed tests, currently not available in the industry for rare ailments.
Growth Drivers
The rise in the funding for research and clinical diagnosis of rare diseases and disorders, for example, hematology testing, by a lot of regulatory authorities and the government, powers the industry.
Moreover, these tests are available at lower cost and can aid in developing a wide range of diagnostic tools for various health conditions.
Also, because of the progression in and microarrays, mass spectrometry, lab-developed tests have evolved since complete authority was given to the FDA to control all the instruments for in vitro diagnoses in the year 1976.
Some LDTs are now numerous times more intricate, accessible across the country, able to notice the risk of breast cancer and Alzheimer's disease; and a lot of other IVD tests, which are under premarket review.
The pandemic has also powered the requirement for these tests because of the massive increase in the count of persons screened at public places and health centers.
Molecular Diagnostics Category Leads the Industry
The molecular diagnostic category led the industry with a 40% share in 2023, and this will continue in the years to come as well. This is because of the development of the aging populace and a growth in the requirement for early disease detection.
The increase in the occurrence of infectious and chronic diseases and the surge in the requirement to control healthcare spending are also fueling the growth, by improving the requirement for early diagnosis of the disease and regular monitoring.
Furthermore, the rising acceptance of molecular diagnostics for examining biological markers in the proteome and genome and cell detection expressions makes the category dominant.
Oncology Category Accounted for Largest Share
On the basis of application, the oncology category leads the industry with a 20% share, because of the growing requirement for tech-advanced molecular diagnosis approaches for the early discovery of cancers. Cancer is the second major cause of death.
So, the growing R&D expenditure in oncology would surge the use of enhanced tests.
Moreover, the enhancements in the healthcare infra of developing nations have led to a large share of the category.
North America Generates the Major Revenue
North America leads the industry, with a share of about 40%, in 2023, and it will power at a robust rate in the years to come as well. This will be attributable to the advanced lab infra and availability of skilled staff in the region.
Furthermore, the elevating menace of ailments in the region, the existence of trustworthy healthcare businesses, and strong support for the setup of novel research and development facilities bode well for the industry.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Volume
- 1.5.2. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Volume, by Type (2017-2030)
- 6.3. Market Revenue, by Type (2017-2030)
- 6.4. Market Volume, by Application (2017-2030)
- 6.5. Market Revenue, by Application (2017-2030)
- 6.6. Market Volume, by End User (2017-2030)
- 6.7. Market Revenue, by End User (2017-2030)
- 6.8. Market Volume, by Region (2017-2030)
- 6.9. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Volume, by Type (2017-2030)
- 7.3. Market Revenue, by Type (2017-2030)
- 7.4. Market Volume, by Application (2017-2030)
- 7.5. Market Revenue, by Application (2017-2030)
- 7.6. Market Volume, by End User (2017-2030)
- 7.7. Market Revenue, by End User (2017-2030)
- 7.8. Market Volume, by Country (2017-2030)
- 7.9. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Volume, by Type (2017-2030)
- 8.3. Market Revenue, by Type (2017-2030)
- 8.4. Market Volume, by Application (2017-2030)
- 8.5. Market Revenue, by Application (2017-2030)
- 8.6. Market Volume, by End User (2017-2030)
- 8.7. Market Revenue, by End User (2017-2030)
- 8.8. Market Volume, by Country (2017-2030)
- 8.9. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Volume, by Type (2017-2030)
- 9.3. Market Revenue, by Type (2017-2030)
- 9.4. Market Volume, by Application (2017-2030)
- 9.5. Market Revenue, by Application (2017-2030)
- 9.6. Market Volume, by End User (2017-2030)
- 9.7. Market Revenue, by End User (2017-2030)
- 9.8. Market Volume, by Country (2017-2030)
- 9.9. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Volume, by Type (2017-2030)
- 10.3. Market Revenue, by Type (2017-2030)
- 10.4. Market Volume, by Application (2017-2030)
- 10.5. Market Revenue, by Application (2017-2030)
- 10.6. Market Volume, by End User (2017-2030)
- 10.7. Market Revenue, by End User (2017-2030)
- 10.8. Market Volume, by Country (2017-2030)
- 10.9. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Volume, by Type (2017-2030)
- 11.3. Market Revenue, by Type (2017-2030)
- 11.4. Market Volume, by Application (2017-2030)
- 11.5. Market Revenue, by Application (2017-2030)
- 11.6. Market Volume, by End User (2017-2030)
- 11.7. Market Revenue, by End User (2017-2030)
- 11.8. Market Volume, by Country (2017-2030)
- 11.9. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Volume, by Type (2017-2030)
- 12.3. Market Revenue, by Type (2017-2030)
- 12.4. Market Volume, by Application (2017-2030)
- 12.5. Market Revenue, by Application (2017-2030)
- 12.6. Market Volume, by End User (2017-2030)
- 12.7. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Volume, by Type (2017-2030)
- 13.3. Market Revenue, by Type (2017-2030)
- 13.4. Market Volume, by Application (2017-2030)
- 13.5. Market Revenue, by Application (2017-2030)
- 13.6. Market Volume, by End User (2017-2030)
- 13.7. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Volume, by Type (2017-2030)
- 14.3. Market Revenue, by Type (2017-2030)
- 14.4. Market Volume, by Application (2017-2030)
- 14.5. Market Revenue, by Application (2017-2030)
- 14.6. Market Volume, by End User (2017-2030)
- 14.7. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Volume, by Type (2017-2030)
- 15.3. Market Revenue, by Type (2017-2030)
- 15.4. Market Volume, by Application (2017-2030)
- 15.5. Market Revenue, by Application (2017-2030)
- 15.6. Market Volume, by End User (2017-2030)
- 15.7. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Volume, by Type (2017-2030)
- 16.3. Market Revenue, by Type (2017-2030)
- 16.4. Market Volume, by Application (2017-2030)
- 16.5. Market Revenue, by Application (2017-2030)
- 16.6. Market Volume, by End User (2017-2030)
- 16.7. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Volume, by Type (2017-2030)
- 17.3. Market Revenue, by Type (2017-2030)
- 17.4. Market Volume, by Application (2017-2030)
- 17.5. Market Revenue, by Application (2017-2030)
- 17.6. Market Volume, by End User (2017-2030)
- 17.7. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Volume, by Type (2017-2030)
- 18.3. Market Revenue, by Type (2017-2030)
- 18.4. Market Volume, by Application (2017-2030)
- 18.5. Market Revenue, by Application (2017-2030)
- 18.6. Market Volume, by End User (2017-2030)
- 18.7. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Volume, by Type (2017-2030)
- 19.3. Market Revenue, by Type (2017-2030)
- 19.4. Market Volume, by Application (2017-2030)
- 19.5. Market Revenue, by Application (2017-2030)
- 19.6. Market Volume, by End User (2017-2030)
- 19.7. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Volume, by Type (2017-2030)
- 20.3. Market Revenue, by Type (2017-2030)
- 20.4. Market Volume, by Application (2017-2030)
- 20.5. Market Revenue, by Application (2017-2030)
- 20.6. Market Volume, by End User (2017-2030)
- 20.7. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Volume, by Type (2017-2030)
- 21.3. Market Revenue, by Type (2017-2030)
- 21.4. Market Volume, by Application (2017-2030)
- 21.5. Market Revenue, by Application (2017-2030)
- 21.6. Market Volume, by End User (2017-2030)
- 21.7. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Volume, by Type (2017-2030)
- 22.3. Market Revenue, by Type (2017-2030)
- 22.4. Market Volume, by Application (2017-2030)
- 22.5. Market Revenue, by Application (2017-2030)
- 22.6. Market Volume, by End User (2017-2030)
- 22.7. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Volume, by Type (2017-2030)
- 23.3. Market Revenue, by Type (2017-2030)
- 23.4. Market Volume, by Application (2017-2030)
- 23.5. Market Revenue, by Application (2017-2030)
- 23.6. Market Volume, by End User (2017-2030)
- 23.7. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Volume, by Type (2017-2030)
- 24.3. Market Revenue, by Type (2017-2030)
- 24.4. Market Volume, by Application (2017-2030)
- 24.5. Market Revenue, by Application (2017-2030)
- 24.6. Market Volume, by End User (2017-2030)
- 24.7. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Volume, by Type (2017-2030)
- 25.3. Market Revenue, by Type (2017-2030)
- 25.4. Market Volume, by Application (2017-2030)
- 25.5. Market Revenue, by Application (2017-2030)
- 25.6. Market Volume, by End User (2017-2030)
- 25.7. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Volume, by Type (2017-2030)
- 26.3. Market Revenue, by Type (2017-2030)
- 26.4. Market Volume, by Application (2017-2030)
- 26.5. Market Revenue, by Application (2017-2030)
- 26.6. Market Volume, by End User (2017-2030)
- 26.7. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Volume, by Type (2017-2030)
- 27.3. Market Revenue, by Type (2017-2030)
- 27.4. Market Volume, by Application (2017-2030)
- 27.5. Market Revenue, by Application (2017-2030)
- 27.6. Market Volume, by End User (2017-2030)
- 27.7. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Volume, by Type (2017-2030)
- 28.3. Market Revenue, by Type (2017-2030)
- 28.4. Market Volume, by Application (2017-2030)
- 28.5. Market Revenue, by Application (2017-2030)
- 28.6. Market Volume, by End User (2017-2030)
- 28.7. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Quest Diagnostics Incorporated
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Abbott Laboratories
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Illumina Inc.
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. F. Hoffmann-La Roche Ltd.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Siemens AG
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Bio-Rad Laboratories Inc.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. NeoGenomics Laboratories Inc.
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Guardant Health Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Becton, Dickinson and Company
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. QIAGEN N.V.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
